 |
answer text |
<p>The Department has held a number of engagement events with representatives of patients
and health professionals in relation to this policy.</p><p>The Department has also
arranged three meetings with stakeholders, ahead of the National Institute for Health
and Care Excellence publishing its guidelines on the prescribing of cannabis-based
products for medicinal use in October 2019. These meetings are attended by relevant
Government departments, public bodies including advisory committees and professional
clinical organisations. The purpose of these meetings is to make sure work, already
commissioned to implement policy on medicinal cannabis, continues to align in the
interim period before the guidelines are issued.</p>
|
 |
